Physician profile
Steven Lomasky
NPI 1891738456
$2,408.21
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,927 · 2020: $325 · 2021: $121 · 2022: $34.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $783.10 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $248.24 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.27 | 2019 | |
| Amgen INC. | $200.76 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $190.55 | 2019-2020 | |
| Insulet Corporation | $94.30 | 2019 | |
| Lilly USA, LLC | $82.45 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $76.49 | 2019 | |
| Dexcom, INC. | $71.04 | 2019-2022 | |
| Amarin Pharma, INC. | $67.35 | 2019 | |
| Tandem Diabetes Care, INC. | $63.77 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $49.31 | 2019 | |
| Abbvie INC. | $46.46 | 2019 | |
| Abbott Laboratories | $42.05 | 2019 | |
| Shire North American Group INC | $39.57 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $37.80 | 2019 | |
| Companion Medical, INC. | $27.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.07 | 2019 | |
| Medtronic Minimed, INC. | $19.57 | 2019 | |
| Horizon Therapeutics Plc | $18.20 | 2019 | |
| Lifescan, INC. | $11.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lomasky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.